Screener
ClearPoint Neuro CLPT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Other accrued liabilities | 2,125 | 2,786 |
| Operating lease liabilities, current portion | 234 | 694 |
| Contract liabilities, current portion | 1,814 | 1,669 |
| Total current liabilities | 9,480 | 10,765 |
| Operating lease liabilities, net of current portion | 13,710 | 8,461 |
| Contract liabilities, net of current portion | 608 | 581 |
| Long-term notes payable, net | 49,644 | 49,077 |
| Deferred tax liabilities, net | 354 | 354 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's total current liabilities?
- ClearPoint Neuro (CLPT) reported total current liabilities of $9.48M in Q1 2026.
- How has ClearPoint Neuro's total current liabilities changed year-over-year?
- ClearPoint Neuro's total current liabilities increased by 38.1% year-over-year, from $6.87M to $9.48M.
- What is the long-term trend for ClearPoint Neuro's total current liabilities?
- Over 5 years (2020 to 2025), ClearPoint Neuro's total current liabilities has grown at a 27.5% compound annual growth rate (CAGR), from $3.2M to $10.77M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about ClearPoint Neuro's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude